ALTSHULER DAVID 4
4 · VERTEX PHARMACEUTICALS INC / MA · Filed Feb 24, 2025
Insider Transaction Report
Form 4
ALTSHULER DAVID
EVP, Chief Scientific Officer
Transactions
- Sale
Common Stock
2025-02-20$480.00/sh−1,111$533,280→ 45,019 total
Footnotes (1)
- [F1]Transaction made pursuant to Dr. Altshuler's company approved trading plan under Rule 10b5-1, which was entered into on 8/8/2024.